Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...
AtaiBeckley's BPL-003 has aligned its research with the FDA's feedback and will proceed with a two-study Phase 3 trial. Read ...
More than 20 years of data show a 37% increase in obesity, 23% in abdominal obesity, and over two-fold increase in severe ...
However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Oath Research, a Gilbert, Arizona–based research peptide supplier, today released an analysis of the regulatory and analytical ...
Pickle juice muscle cramps may be relieved via a nerve reflex, not electrolyte replacement, research shows. The post Does ...
If you want to understand which substances have appeared in football doping cases, why players use them, and what the ...
Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...
As of Tuesday, July 07, Protagonist Therapeutics, Inc.’s PTGX share price has surged by 5.03%, which has investors ...
An international research team co-led by the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC-CSIC-University ...
Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...